TechCreate director reports deferred share award
TechCreate Group Ltd. director Tagai Masayuki reported his initial equity holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TechCreate Group Ltd. director Tagai Masayuki reported his initial equity holdings. The filing shows a deferred share award tied to 2,500 Class A Ordinary Shares, with an exercise price of $0.0000. According to a footnote, this award was granted on December 1, 2025 and is scheduled to vest on May 31, 2026, and is share-settled with no shares issued as of the reporting date. The filing also shows 0 Class A Ordinary Shares and 0 Class B Ordinary Shares held directly as of the same date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Deferred Share Award | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
| holding | Class B Ordinary Shares | -- | -- | -- |
Footnotes (2)
- F1. Deferred share award granted on December 1, 2025, vesting on May 31, 2026, share-settled with no shares issued as of the date hereof.
- F2. Not Available.
Key Figures
Key Terms
Form 3 regulatory
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the TechCreate Group Ltd. (TCGL) Form 3 filing show for Tagai Masayuki?
AI-generated analysis. How Rhea-AI works. Not financial advice.